Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Feb 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 61791000001115 | Glycopyrronium bromide + Formoterol | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 61801000001116 | Glycopyrronium bromide + Formoterol (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Glycopyrronium bromide + Formoterol | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Glycopyrronium bromide + Formoterol | Is a | Product containing muscarinic receptor antagonist | true | Inferred relationship | Existential restriction modifier | ||
| Glycopyrronium bromide + Formoterol | Is a | Product containing beta-2 adrenergic receptor agonist | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Glycopyrronium 7.2micrograms/dose / Formoterol 5micrograms/dose inhaler CFC free | Is a | True | Glycopyrronium bromide + Formoterol | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR